Charles German to Atherosclerosis
This is a "connection" page, showing publications Charles German has written about Atherosclerosis.
Connection Strength
3.627
-
Early Inclisiran Use in Atherosclerotic Cardiovascular Disease: Overcoming Therapeutic Inertia. J Am Coll Cardiol. 2024 May 21; 83(20):1953-1956.
Score: 0.736
-
Charting a Course for Atherosclerosis Regression: Shifting the Paradigm. J Am Coll Cardiol. 2023 11 28; 82(22):2084-2086.
Score: 0.712
-
Physical Activity, Coronary Artery Calcium, and Cardiovascular Outcomes in the Multi-Ethnic Study of Atherosclerosis (MESA). Med Sci Sports Exerc. 2022 05 01; 54(5):800-806.
Score: 0.624
-
Implications of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline in a Modern Primary Prevention Multi-Ethnic Prospective Cohort (Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2019 04 01; 123(7):1076-1082.
Score: 0.507
-
Association of silent myocardial infarction on electrocardiogram and coronary artery calcium: The Multi-Ethnic Study of Atherosclerosis. Ann Noninvasive Electrocardiol. 2023 09; 28(5):e13081.
Score: 0.174
-
Circulating ketone bodies and cardiovascular outcomes: the MESA study. Eur Heart J. 2023 05 07; 44(18):1636-1646.
Score: 0.171
-
Should a Statin be Given to All Hypertensive Patients? Curr Hypertens Rep. 2022 01; 24(1):21-27.
Score: 0.157
-
The utility of silent myocardial infarction on electrocardiogram as an ASCVD risk enhancer for primary prevention: The multi-ethnic study of atherosclerosis. J Electrocardiol. 2021 Mar-Apr; 65:105-109.
Score: 0.146
-
Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9. BioDrugs. 2020 Feb; 34(1):1-9.
Score: 0.137
-
Associations between BMI, waist circumference, central obesity and outcomes in type II diabetes mellitus: The ACCORD Trial. J Diabetes Complications. 2020 03; 34(3):107499.
Score: 0.135
-
Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial. J Diabetes Complications. 2019 07; 33(7):468-472.
Score: 0.129